| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Heparin sodium can interfere with many aspects of the blood coagulation process, and has anticoagulant effects both inside and outside the body. Its mechanism of action is more complicated, mainly through binding to antithrombin III (AT-III), which enhances the latter's inhibitory effect on activated coagulation factors II, IX, X, XI and XII, and its consequences involve prevention of platelet aggregation and Destroy and hinder the formation of thrombin activating enzyme, prevent prothrombin from turning into thrombin, inhibit thrombin, thereby preventing fibrinogen from turning into fibrin, thereby exerting an anticoagulant effect.
|
Product Name
|
Heparin sodium |
|
CAS
|
9041-08-1 |
|
Appearance
|
White to off-white powder |
|
MF
|
(C12H16NS2Na3)20 |
|
Molecular Weight
|
288.428 |
|
Purity
|
99% min
|
|
Storage
|
Keep in a cool, dry, dark location in a tightly sealed container or cylinder
|
|
Shelf Life
|
24 Months
|
| Items | Specifications | Results | |
| Characters | White to off white powder | Complies | |
| Solubility | Freely soluble in water | Complies | |
| Identificatin | A; Delay of cloting of recalcified cimated sheep plasma. B;1H-NMR Spectrum; Comply with the EP speacification of heparin about 1H-NMR requiremenls. C; The principal peak in the chromatogram obtained with test solution is similar in retention time and shape to the principal peak in the chromatogram obtained with reference solution. D; Positive sodium reaction. |
Complies Complies Complies Complies |
|
| PH | 5.5~8.0 | 6.6 | |
| Realated substances | A:Sum of dermantan sulfate and chondroitin sulfate:≤2.0% B:Any other impurity Free |
Complies Complies |
|
| Appearance of solution | A:5%w/v solution is clear and colourlesss B:Solution is not more inicnscly coloured than reference solution BY5 or better |
Complies Complies |
|
| Heavy metals | ≤30ppm | Complies | |
| Loss on drying | ≤8.0% | 1.4% | |
| Protein | ≤0.5% | 0.07% | |
| Nitrogen | 1.5%~2.5% | 2.2% | |
| Sodium | 9.5%~12.5% | 12.1% | |
| Sulphated ash | 28%~41.0% | 37.3% | |
| Nueleotide impurlties | 260nm≤0.15 | 260n 0.07 | |
| Microbial contamination | A: Total viable acrobic count: max.10 CFU/g B;Fung yeasts: max. 10 CFU/g C; Specified micro orgnisms Escherichina coli Salmonclla Pscudomonas aeruginosa |
10 CFU/g 10 CFU/g Negative Negative Negative |
|
| Residual solvents | Ethanol: Not more than 5000 ppm | 955ppm | |
| Bacterial endotoxins | 0.01IU/IU of heparin | Complies | |
| Impurlfy (NMR) | The N-acetyl protons of heparin show a single peak at 2.04±0.02ppm No peak should be visible at 2.16±0.03ppm |
Complies | |
| POTENCY | ≥180 u/mg | 194 u/mg | |
1. Prevent thrombosis and embolism, such as deep vein thrombosis, myocardial infarction, pulmonary embolism, thrombophlebitis and postoperative thrombosis.| Name | CAS No. | Purity |
| Sunifiram | 314728-85-3 | 99.0% |
| Unifiram | 272786-64-8 | 99.0% |
| Idebenone | 58186-27-9 | 99.0% |
| Pramiracetam | 68497-62-1 | 99.0% |
| Fasoracetam | 110958-19-5 | 99.0% |
| Oxiracetam | 62613-82-5 | 99.0% |
| Phenylpiracetam hydrazide | 77472-71-0 | 99.0% |
| Galantamine Hydrobromide | 69353-21-5 | 98.0% |
| Tianeptine | 66981-73-5 | 99.0% |
| Tianeptine sodium | 30123-17-2 | 99.0% |
| Tianeptine hemisulfate monohydrate (THM) | 1224690-84-9 | 99.0% |
| 9-ME-BC(9-Methyl-9H-beta-carboline) | 2521/7/5 | 99.0% |
| Agomelatine | 138112-76-2 | 99.0% |
| 6-Paradol 98% | 27113-22-0 | 98% Oil form |
| 6-Paradol 50% | 27113-22-0 | 50% Powder form |
| Nicotinamide Riboside Chloride(NRC) | 23111-00-4 | 98.0% |
| Beta-Nicotinamide Mononucleotide(NMN) | 1094-61-7 | 99.0% |
| β-Nicotinamide Adenine Dinucleotide(NAD+) | 53-84-9 | 98.0% |
| Noopept,GVS-111 | 157115-85-0 | 99.0% |
| Piracetam | 7491-74-9 | 99.0% |
| Phenibut | 1078-21-3 | 99.0% |
| Coluracetam | 135463-81-9 | 99.0% |
| N-Methyl-D-aspartic acid(NMDA) | 6384-92-5 | 99.0% |
| Alpha GPC(Choline Alfoscerate) | 28319-77-9 | 99% Powder form |
| Alpha GPC(Choline Alfoscerate) | 28319-77-9 | 50% Graininess form |
| Citicoline | 987-78-0 | 99.0% |
| PRL-8-53 | 51352-87-5 | 98.0% |
| NSI-189 Phosphate | 1270138-41-4 | 99.0% |
Xi'an Biohorlden Industry&Trade Co.,Ltd is a national key high-tech enterprise,which mainly specializes in the R&D, operation and production of pharmaceuticals,and intermediates.Our company is situated in E&T development zone,xi'an city shaanxi,it is easy of access. Our company has independent R&D center,raw material synthesis workshop, has advanced quality instruments and equipmentm,several product patents there are 15 experts in our research team.We insist in innovation and produce high quality products.
){kind=link}